Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
暂无分享,去创建一个
M. von Knebel Doeberitz | H. Najafabadi | J. Hoheisel | M. Büchler | M. Fassan | M. Lathrop | Andrea S Bauer | Sidong Huang | W. Greenhalf | Eithne Costello | A. Scarpa | J. Neoptolemos | N. Giese | B. Sipos | Morag Park | Y. Riazalhosseini | Pouria Jandaghi | A. Papadakis | D. Auld | T. Hackert | O. Strobel | G. Zogopoulos | A. Hall | V. Sangwan | A. Monast
[1] Anneleen Daemen,et al. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors , 2015, Proceedings of the National Academy of Sciences.
[2] Carol L. Williams,et al. Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells , 2015, Molecular carcinogenesis.
[3] A. Barabasi,et al. Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.
[4] Dustin J Maly,et al. Druggable sensors of the unfolded protein response. , 2014, Nature chemical biology.
[5] Joseph E Chambers,et al. Endoplasmic reticulum stress in malignancy. , 2014, Cancer cell.
[6] F. Bendtsen,et al. Mortality, cancer, and comorbidities associated with chronic pancreatitis: a Danish nationwide matched-cohort study. , 2014, Gastroenterology.
[7] W. Cavenee,et al. Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma , 2014, Oncotarget.
[8] S. Sampson,et al. Pimozide for schizophrenia or related psychoses. , 2013, The Cochrane database of systematic reviews.
[9] T. Gonen,et al. Local cAMP signaling in disease at a glance , 2013, Journal of Cell Science.
[10] B. Mollereau. Establishing Links between Endoplasmic Reticulum-Mediated Hormesis and Cancer , 2013, Molecular and Cellular Biology.
[11] W. Greenhalf,et al. New biomarkers and targets in pancreatic cancer and their application to treatment , 2012, Nature Reviews Gastroenterology &Hepatology.
[12] B. Leber,et al. Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells , 2012, Cell.
[13] M. Mattson,et al. Endoplasmic Reticulum Ca2+ Handling in Excitable Cells in Health and Disease , 2011, Pharmacological Reviews.
[14] F. Sinicrope,et al. The Role of Autophagy in Cancer: Therapeutic Implications , 2011, Molecular Cancer Therapeutics.
[15] Y. Ye,et al. Proteostasis regulation at the endoplasmic reticulum: a new perturbation site for targeted cancer therapy , 2011, Cell Research.
[16] J. Taieb,et al. Medical treatment of pancreatic cancer: new hopes after 10 years of gemcitabine. , 2011, Clinics and research in hepatology and gastroenterology.
[17] P. Spellman,et al. Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy , 2011, Nature Medicine.
[18] Kezhong Zhang,et al. Unfolded protein response in cancer: the Physician's perspective , 2011, Journal of hematology & oncology.
[19] C. Croce,et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. , 2010, Cancer research.
[20] J. Javitch,et al. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. , 2010, The American journal of psychiatry.
[21] Taufiq Rahman,et al. Regulation of Inositol 1,4,5-Trisphosphate Receptors by cAMP Independent of cAMP-dependent Protein Kinase , 2010, The Journal of Biological Chemistry.
[22] Malcolm K Horne,et al. Dopamine D2 receptor knockout mice develop features of Parkinson disease , 2009, Annals of neurology.
[23] J. Gogos,et al. A signaling pathway AKTing up in schizophrenia. , 2008, The Journal of clinical investigation.
[24] G. Gallick,et al. Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players , 2008, Clinical Cancer Research.
[25] J. Buring,et al. A Prospective Cohort Study of Cancer Incidence Following the Diagnosis of Parkinson's Disease , 2007, Cancer Epidemiology Biomarkers & Prevention.
[26] S. Kondo,et al. DRD2/DARPP-32 Expression Correlates with Lymph Node Metastasis and Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma , 2006, World Journal of Surgery.
[27] R. Hamanaka,et al. PERK and GCN2 contribute to eIF2alpha phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway. , 2005, Molecular biology of the cell.
[28] B. Granger,et al. The haloperidol story. , 2005, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[29] Christoffer Johansen,et al. Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969–1993 , 2005, Schizophrenia Research.
[30] Prahlad T. Ram,et al. G Protein Pathways , 2002, Science.
[31] P. Cohen,et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors , 2000 .
[32] Johannes Gerdes,et al. The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.
[33] C. Sherr,et al. Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Habener,et al. cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37). , 1999, The Journal of biological chemistry.
[35] L. Bristow,et al. Antagonism of the effects of (+)‐PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L‐741,626 , 1996, British journal of pharmacology.
[36] J. Lytton,et al. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. , 1991, The Journal of biological chemistry.
[37] D. Tormey,et al. Phase II trial of the dopaminergic inhibitor pimozide in previously treated melanoma patients. , 1983, Cancer treatment reports.
[38] A. Jemal,et al. Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.
[39] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..